CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1989; 39:231-247
doi: 10.3322/canjclin.39.4.231
© 1989 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zollinger, R. M.
Right arrow Articles by Ellison, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zollinger, R. M.
Right arrow Articles by Ellison, E. H.

CA: A Cancer Journal for Clinicians, Vol 39, 231-247, Copyright © 1989 by American Cancer Society


Primary Peptic Ulcerations of the Jejunum Associated with Islet Cell Tumors of the Pancreas

Robert M. Zollinger MD1 and Edwin H. Ellison MD2

1 Department of Surgery and the Medical Center of Ohio State University College of Medicine in Columbus, Ohio. Professor and Chairman of the Department of Surgery at that institution for many years.
2 Department of Surgery and the Medical Center of Ohio State University College of Medicine in Columbus, Ohio.

1. Two instances of primary nonspecific jejunal ulcers associated with marked gastric hypersecretion and hyperacidity have been studied. Recurrent ulceration followed standard surgical therapy in both cases and necessitated total gastrectomy.

2. In each patient, nonspecific islet cell tumors of the pancreas were eventually found.

3. Four additional similar cases found in the literature are reviewed.

4. An ulcerogenic humoral factor of pancreatic islet origin is postulated.

5. Theoretical reasons are given for implicating the hyperglycemic-glycogenolytic factor of the pancreas (glucagon).

6. In the one living patient available for study, an electrophoretic analysis of the patient's serum demonstrated a protein fraction with mobility characteristics similar to those of glucagon. This fraction, not found in normal serum, elicited a hyperglycemic response in experimental animals.

7. A clinical entity consisting of hypersecretion, hyperacidity, and atypical peptic ulceration associated with non-insulin-producing islet cell tumors of the pancreas is suggested.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by American Cancer Society.